HealthDay - FRIDAY, April 25 (HealthDay News) -- The U.S. Food and Drug Administration has approved Relistor (methylnaltrexone bromide) to treat constipation stemming from continuous use of opioid painkillers.
More: - Continued here
Name(required)
Mail (will not be published)(required)
Website
Notify me of followup comments via e-mail.